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The human polynucleotide cytidine deaminases APOBEC3G (hA3G) and APOBEC3F (hA3F) are antiviral
restriction factors capable of inducing extensive plus-strand guanine-to-adenine (G-to-A) hypermutation in a
variety of retroviruses and retroelements, including human immunodeficiency virus type 1 (HIV-1). They differ
in target specificity, favoring plus-strand 5GG and 5GA dinucleotide motifs, respectively. To characterize
their mutational preferences in detail, we analyzed single-copy, near-full-length HIV-1 proviruses which had
been hypermutated in vitro by hA3G or hA3F. hA3-induced G-to-A mutation rates were significantly influenced
by the wider sequence context of the target G. Moreover, hA3G, and to a lesser extent hA3F, displayed clear
tetranucleotide preference hierarchies, irrespective of the genomic region examined and overall hypermutation
rate. We similarly analyzed patient-derived hypermutated HIV-1 genomes using a new method for estimating
reference sequences. The majority of these, regardless of subtype, carried signatures of hypermutation that
strongly correlated with those induced in vitro by hA3G. Analysis of genome-wide hA3-induced mutational
profiles confirmed that hypermutation levels were reduced downstream of the polypurine tracts. Additionally,
while hA3G mutations were found throughout the genome, hA3F often intensely mutated shorter regions, the
locations of which varied between proviruses. We extended our analysis to human endogenous retroviruses
(HERVs) from the HERV-K(HML2) family, finding two elements that carried clear footprints of hA3G activity.
This constitutes the most direct evidence to date for hA3G activity in the context of natural HERV infections,
demonstrating the involvement of this restriction factor in defense against retroviral attacks over millions of
years of human evolution.
Human immunodeficiency virus type 1 (HIV-1) infection is
characterized by the development of considerable genetic vari-
ation in the viral population and continuous evolution and
adaptation of the virus to its host (4, 9). This variation results
from a combination of high viral replication rates, large viral
population sizes, and the inherent infidelity of the viral reverse
transcriptase (RT), as well as recombination, and is driven by
various selective pressures in the infected host (62). Mutations
may additionally be induced in HIV-1 proviruses by members
of the APOBEC3 (apolipoprotein B mRNA-editing enzyme,
catalytic polypeptide-like 3, or hA3) family of human cytidine
deaminases, which form part of the innate antiviral defense
system and are capable of specifically inducing plus-strand
guanine-to-adenine (G-to-A) mutations (6, 26, 44, 47, 52, 66,
90, 92). As these mutations usually occur at a very high fre-
quency in affected sequences, they are collectively termed hy-
permutation and typically result in viral inactivation (79).
hA3G and hA3F are the most thoroughly investigated mem-
bers of the hA3 family; both exhibit potent anti-HIV-1 activity
(6, 47, 66, 83, 88, 92) and are expressed at high levels in
lymphocytes, the major target cells for HIV-1 infection (47,
83). The activity of these proteins is counteracted by the HIV-1
accessory protein Vif, which prevents hA3 incorporation into
virions during assembly by targeting them for degradation
through the ubiquitin-proteasome pathway (15, 35, 48, 53, 67,
87). In the absence of Vif, hA3 proteins become incorporated
into progeny virions in an infected cell, and when such a virion
subsequently infects another cell, they act to restrict viral rep-
lication (26, 66).
The hA3 proteins target the single-stranded minus-strand
DNA intermediate of the HIV-1 reverse transcription reac-
tion, which results in extensive cytosine-to-uracil (C-to-U)
deamination (26, 44, 52, 73, 86, 90). Minus-strand C-to-U mu-
tations subsequently become fixed as plus-strand G-to-A
changes; reporting of hypermutation conventionally makes ref-
erence to changes occurring on the plus strand. In addition,
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hA3 proteins might also restrict HIV-1 replication through
hypermutation-independent mechanisms (5, 24, 25, 28, 31, 46,
50, 54, 57, 59, 64, 85). The presence of proviruses carrying
G-to-A hypermutations in sequence sets derived from natural
infections suggests that hA3 proteins occasionally circumvent
HIV-1 Vif in vivo (32, 38, 40, 78).
Previous in vitro analyses of both hypermutated subgenomic
HIV-1 fragments and non-HIV-1 sequences have identified
some sequence preferences for hA3G and hA3F cytidine
deamination; they preferentially cause G-to-A mutations at
plus-strand 5GG or 5GA dinucleotide motifs, respectively
(target nucleotide underlined) (1, 6, 13, 26, 47, 73, 86, 90).
Furthermore, hA3G has been shown to favor 5TGGG and
disfavor 5nGGC contexts, while hA3F preferentially causes
mutations at 5WGAA (W equals A/T) motifs (1, 6, 13, 47, 73,
86). The preference of hA3G for 5TGG-to-5TAG (trypto-
phan to stop codon) mutations explains why hypermutation
commonly results in premature truncation of viral proteins. In
addition, several recent studies have presented results suggest-
ing that, at the genome-wide level, hA3G induces twin gradi-
ents of hypermutation, increasing from the central and 3 poly-
purine tracts (cPPT and 3PPT) (60, 72, 84, 86). Second-strand
synthesis during reverse transcription is initiated from these
motifs, and hypermutation is thought to be most intense in the
regions furthest from them, which are exposed as single-
stranded DNA substrates for the longest times (72, 86).
To characterize hA3G and hA3F mutational preferences in
greater detail, we analyzed sets of near-full-length HIV-1 se-
quences that had been hypermutated by either hA3G or hA3F
in single infection cycles in vitro and evaluated the local and
genome-wide context preferences for each deaminase (1, 47,
86). We show that hA3G- and hA3F-induced G-to-A mutation
rates are significantly influenced by the wider nucleotide con-
text of the target G. Then, through analyzing mutation rates at
different types of overlapping G-containing tetranucleotide
motifs, we demonstrate that hA3G and, to a lesser extent,
hA3F display clear hierarchies of tetranucleotide preferences,
which are manifested irrespective of the genomic region ex-
amined and the overall hypermutation rate. By analyzing hy-
permutated sequences from HIV-positive patients using a
novel method to generate reference sequences, we show that
the majority of these carry signatures strongly correlating with
those induced by hA3G in vitro. Moreover, we confirm the
influence of the PPTs on the genome-wide hypermutation pro-
files and demonstrate that the profiles induced by hA3G and
hA3F are distinct.
The hA3 family has also been demonstrated to restrict rep-
lication of other viruses and retroelements (e.g., hepatitis B
virus [75]), endogenous long terminal repeat (LTR) retroele-
ments (e.g., the murine MusD and IAP [19, 21], and yeast Ty1
retroelements [17, 65]), and non-LTR endogenous retrotrans-
posons (e.g., Alu [8, 14] and L1 [58, 70]). Here, we analyzed
whether there was evidence of hA3 activity in HERV infec-
tions. HERVs constitute approximately 5 to 8% of the human
genome (41) and are assumed to have become fixed in the
population following infection of germ cells and transmission
to offspring (3). The most recently active HERVs belong to the
HERV-K(HML2) family, of which many elements are unique
to humans (2, 56). No replication-competent HERV-K
(HML2) elements have been isolated; most carry multiple
frameshift mutations, premature stop codons, or have under-
gone recombinational deletion between the two viral LTRs
(76). However, active HERV-K(HML2) elements may still
circulate at low frequencies in human populations (2, 3).
Several lines of evidence are consistent with a role for the A3
proteins in the innate defense against attacks by endogenous
retroviruses (27, 36, 63). First, G-to-A mutations consistent
with murine A3 (mA3) activity are present in proviruses from
the Pmv and Mpnv subgroups of endogenous nonecotropic
murine leukemia viruses (MLVs) that are fixed in the mouse
genome, suggesting this deaminase may have contributed to
their inactivation (34). Second, phylogenetic analysis has dem-
onstrated that the hA3 family has been subject to extremely
strong positive selection throughout primate evolution (63,
91), predating the oldest known lentiviruses (37). Third, hA3G
and hA3F are expressed at high levels in testes and ovaries,
where infection of germ line cells must take place for fixation
of endogenous retroelements to occur (33, 77). Furthermore,
recent results demonstrated that a reconstituted HERV-
K(HML2) element could be inhibited by hA3F in vitro (45).
Here, we find mutational footprints strongly correlating with
those induced by hA3G on HIV-1 in vitro and in vivo and in
two naturally occurring hypermutated HERV-K(HML2) ele-
ments. Our analysis provides the most direct evidence to date
of hA3G-mediated restriction of HERVs during human evo-
lution and may also highlight novel features of the HERV-
K(HML2) replication strategy.
MATERIALS AND METHODS
PCR amplification and sequencing of proviruses hypermutated by hA3G or
hA3F in vitro. Total DNA was extracted from 293T cells infected for 24 h with
the G protein of vesicular stomatitis virus (VSV-G)-pseudotyped vif-deficient
HIV-1IIIB viruses produced in the presence of hA3G or hA3F, as previously
described (6). Following DpnI treatment to eliminate carry-over transfection
mixture, near-full-length single HIV-1 proviruses were amplified by limiting
dilution nested PCR using the Advantage 2 polymerase mix (TakaraBio/Clon-
tech, Paris, France). All primers used were designed where possible to anneal to
sites lacking 5GG or 5GA (forward primers) or 5CC or 5TC (reverse primers)
motifs (the preferred contexts for hA3G and hA3F activity, respectively), to
reduce the potential for inefficient amplification of hypermutated viruses. When
it was not possible to design a suitable primer lacking these motifs, primers were
designed with the motifs restricted to the 5 end. All PCR primer sequences are
given in Table S1 of the supplemental material. First-round PCR resulted in the
amplification of an 8.5-kb fragment spanning the gag-to-3LTR region; this
amplicon was used as a template for four second-round PCRs amplifying gag-
to-pol, pol-to-vif, vif-to-env, and env-to-3LTR fragments. The PCR conditions
were identical for both first- and second-round PCRs: 95°C (1 min) hot start,
followed by 15 cycles of 95°C denaturation (30 s), 60°C annealing (30 s), and 68°C
extension (10 min), and then 20 cycles consisting of 95°C denaturation (30 s) and
68°C annealing/extension (10 min), with a final cycle of extension at 68°C (extra
10 min). Amplicons were visualized on 1% agarose gels in Tris-acetate-EDTA
containing 0.4 ng/l ethidium bromide and purified using the QIAquick PCR
purification kit (Qiagen, CA); they were sequenced from both directions using
the primers listed in Table S1 in the supplemental material by using the
Dyedeoxy terminator sequencing system (Applied Biosystems, CA) on an Ap-
plied Biosystems 3730xl DNA analyzer. DNA reads were assembled and proof-
read using Pregap4 and Gap4 within the Staden package (69); sequences with
multiple peaks at the same nucleotide position were assumed to represent mul-
tiple proviruses within the starting PCR mix and so were discarded. Sequences
lacking a G-to-A mutation in the 3LTR, copied from the engineered G-to-A
mutation at HXB2 position 571 during reverse transcription (6), were assumed
to be carry-over transfection mixture and were therefore also discarded. Se-
quences were aligned using a pairwise alignment algorithm with the MacClade
software (51), followed by manual adjustment. The alignments generated are
given in Fasta format in Fig. S1 of the supplemental material.
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Analysis of hypermutated sequences. To analyze the local nucleotide substrate
preferences of hA3G/hA3F activity in a given query sequence, the numbers of (i)
guanine bases, (ii) dinucleotide contexts containing guanine (5Gn [target gua-
nine underlined; n represents any nucleotide]), and (iii) tetranucleotide contexts
containing guanine (5Gnnn, 5nGnn, and 5nnGn) were determined for a rel-
evant reference sequence. The number of these contexts carrying guanine-to-
adenine (G-to-A) mutations in the query sequence were then counted, such that
the proportion of each type of context carrying G-to-A mutations could be
calculated. In our analysis, each G-to-A mutation was considered independently
and its context was defined by the index nucleotides in the parental virus se-
quence. C-to-T, CC-to-CT, and TC-to-TT mutation rates were assessed in some
cases to give an indication of the noise associated with certain analyses. In cases
where more than a single G-to-A mutation occurred within a particular tet-
ranucleotide (e.g., 5GnGn to 5AnAn), misreporting of the context of one or the
other mutation was likely (but not definite), depending on which guanine was
mutated first, the separation of the mutated Gs in the tetranucleotide (i.e.,
5nGGn, 5nGnG, or 5GnnG) and the particular tetranucleotide analysis being
employed (i.e., 5Gnnn, 5nGnn, or 5nnGn).
To assess the extent of potential misreporting of the contexts of G-to-A
mutations in these data sets, we determined the number of mutations occurring
within three nucleotides of other mutations (data not shown). The analysis
showed that a maximum of approximately 12.6% of the hA3G-induced G-to-A
mutations and 20.9% of hA3F-induced G-to-A mutations were potentially mis-
reported. Eliminating tetranucleotides carrying multiple G-to-A mutations from
the analysis might remove this potentially confounding factor but would create a
new one, since these sites clearly constitute prime targets for hA3 activity. There
is some evidence that the 5G in a poly(G) motif is most likely to be mutated first
by hA3G in vitro (13), and the apparent preference of this deaminase for
5TGGG over 5TGGG in our data set is consistent with this notion. This effect
could potentially be modeled into the analysis, but this approach would still
depend on assumptions, which may thwart the results as mentioned above, and
therefore has not been carried out here. Furthermore, this discussion still as-
sumes that each mutation does occur independently, but it is possible that a
cooperative effect may operate. A second mutation may be more likely in the
vicinity of a recently induced mutation.
In some experiments, data for individual sequences were pooled to summarize
results and to increase statistical power. Profiles of G-to-A mutational burden
across individual hypermutated genomes were generated by first counting the
number of target (GG and GA) motifs within a 400-bp sliding window to the 3
of a given base of a reference sequence (advancing in single nucleotide steps),
and second, counting the number of these target motifs carrying a GG-to-AG or
GA-to-AA mutation. Using these data, plots of the proportion of target motifs
across hypermutated genomes were constructed.
Statistical analyses. To assess the influence of the wider nucleotide context on
G-to-A mutation rates, chi-square tests were performed. For each individual
near-full-length provirus hypermutated in vitro by hA3G or hA3F, the indepen-
dence of G-to-A mutation rates on the nucleotide at each position spanning the
region from 100 bp upstream of the target G to 100 bp downstream was deter-
mined (chi-square test, three degrees of freedom). To identify the nucleotides in
each entire data set that influenced mutation rates, the P values derived from the
chi-square analyses of individual proviruses were combined using Fisher’s
method for combining independent tests (22). To investigate which particular
nucleotides contributed to the effects, observed nucleotide frequencies relative to
those expected under independence were plotted.
To determine whether the hypermutation preferences observed in one se-
quence or set of sequences predicted those observed in a second sequence or set
of sequences, the relationship between the arrays of observed mutation rates at
each relevant context in the two data sets was tested. This was assessed in two
ways. First, we used Poisson regression with an identity link function, weight-
ing errors to take into account the different number of contexts available for
mutation under the response conditions (55). The goodness of fit of these
regression lines was assessed using McFadden’s pseudo-R2 [defined as 1 
(log likelihood of the linear model)/(log likelihood for the null model)], which
accounts for the number of available target contexts. However, the P values
of these regressions, as determined from a likelihood ratio test, were liberal
due to the stronger influence of points where the observed mutation rate in
the predictor variable was very small. Accordingly, we also tested the strength
of correlation using Spearman’s rank correlation test, a conservative non-
parametric statistic that is robust to the misspecification of errors. For both
tests, contexts where the observed mutation rate was zero (i.e., where no
contexts were mutated) were excluded because such data are unsuitable for
the Poisson regression analysis and since a large number of tied ranks can
compromise Spearman’s test.
Analysis of hypermutation in sequences derived from HIV-1-infected patients
for which no parental sequence is available. For an ideal hypermutation analysis,
hypermutated sequences should be compared with their parental sequence (i.e.,
the sequence from the previous replication cycle). This is possible in vitro;
however, in natural infections, the exact parental sequence is invariably un-
known. Some previous studies have used consensus sequences derived from
nonhypermutated sequences from the same patient, but no such sequences were
available for the majority of hypermutated near-full-length HIV genomes in the
Los Alamos Sequence database (http://www.hiv.lanl.gov/hiv-db) (32, 38, 40, 72).
We therefore developed a method to improve the generation of reference se-
quence estimates for analysis of hypermutated sequences. Phylogenetic trees are
useful for identifying closely related taxa; unfortunately, hypermutated se-
quences skew trees, often clustering together (due to common G-to-A muta-
tions) and bearing long branches (due to larger numbers of mutations). To
remove the skewing effect of hypermutation, sites in sequence alignments where
the hA3 proteins may have recently acted (i.e., sites represented by both GG and
AG or by GA and AA dinucleotide motifs) were “repaired”: at such sites, AG
and AA were repaired to NG and NA, respectively. Phylogenetic trees recon-
structed from such repaired sequence alignments were presumed to be minimally
influenced by recent hA3 activity, since N makes no contribution to the con-
struction of the tree, and therefore depict more genuine phylogenetic relation-
ships. Thus, sequences closely related to the hypermutated sequence can be
identified, without the skewing effect of hypermutation. This is a conservative
approach for removing the influence of hA3-type mutations, yet it will also
remove the signal of variation caused by other means, such as reverse transcrip-
tion; however, typically no more than 20% of sequence information was lost
through this approach, leaving a large amount of sequence data from which
phylogenetic relationships could be inferred.
We downloaded all hypermutated and nonhypermutated sequences from a
given subtype from the database, having carried out a search for complete
genomes, including problematic sequences. We aligned and “repaired” the se-
quences as described above; neighbor-joining trees were constructed using the
“repaired” alignments according to the Felstenstein 84 (F84) model of nucleo-
tide substitution using the PAUP* software (74). A subset of sequences cluster-
ing with the hypermutated sequence was then identified and reextracted from the
database. The hypermutated sequence was removed from this alignment, and the
consensus nucleotide at each position was derived from the remaining nonhy-
permutated sequences (using a 50% majority rule as implemented by the Se-Al
software [http://tree.bio.ed.ac.uk/software/seal/]) to give an estimate of a refer-
ence sequence against which the hypermutated isolate could be analyzed. The
hypermutated sequence was realigned to this reference for analysis as described
above. The method is limited by the genetic distance from the available neighbor
taxa, which will be minimized when sequences are available from the same
patient, or at least the same local epidemic. In several cases, only one or a few
sequences of the same subtype are present in the database, and consequently the
level of noise in such analyses may be higher.
We generated reference sequences specific for each of the hypermutated
proviruses present in the Los Alamos database at the time of writing, which
belonged to subtypes also represented by nonhypermutated sequences (accession
numbers are listed in Table S2 in the supplemental material).
Analysis of HERV-K (HML2) sequences. For a preliminary screen of HERV-
K(HML2) proviral elements for evidence of hA3-mediated hypermutation, each
proviral sequence was aligned to a consensus sequence of the one of the two
major HERV-K(HML2) lineages to which it belonged, which was used as a
reference sequence (3). Near-full-length proviruses spanning gag to the 3LTR
were analyzed; the 292-bp sequence at the pol-env boundary of type 2 HERV-
K(HML2) isolates was omitted from the analysis (49). For each provirus, GN-
to-AN mutation rates were determined, relative to the appropriate consensus
sequence. Two-by-two chi-square tests for the independence of G-to-A mutation
rates with respect to the presence of a purine (R A or G) or a pyrimidine (Y
C or T) at the 1 position were carried out. HERV-K(HML2) elements for
which there was evidence of dependence of mutation rates on the type of
downstream nucleotide after Bonferroni correction for multiple testing (P 
[0.05/n], where n  number of independent tests) were analyzed further, using
the method described above for analysis of hypermutated HIV sequences from
the Los Alamos database (hypermutation of HIV-1 sequences by hA3 proteins in
vitro showed a marked bias for inducing mutation at GR dinucleotides, com-
pared with GY). Elements 79c12, 74c19, 154c11, 102c6, 8c8, 2c7, K113, K103,
5c22, 172c1, 196c5, 140c3, 84c1, 3q27, 39c5, and 110c10 were used to generate a
reference sequence estimate for elements 11c21 and 158c3; elements 119c9,
88c11, 83c19, and 30c19 were used to generate a reference estimate for 103c19.
The chromosomal locations of the 44 HERV-K(HML2) elements included in
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this analysis are given in Table S3 of the supplemental material, and the align-
ment used in the analysis is presented in Fig. S3 of the supplemental material.
The HERV-K(HML2) tree was constructed by maximum likelihood using
PAUP* 4.0b10 (74) and the GTR model of nucleotide substitution, based on
an alignment of the protein-coding regions (gag to env) of the HERV-K(HML2)
elements. We employed a heuristic search, starting with a neighbor-joining tree,
followed by two successive rounds of branch swapping (TBR and NNI) and
parameter optimization. hA3-type mutations within the hypermutated elements
11c21 and 158c3 were repaired prior to construction of the tree.
RESULTS
Sequence preferences for hA3-mediated hypermutation of
HIV-1 proviruses in vitro. To characterize the mutational pref-
erences of hA3G and hA3F, we carried out infections of 293T
cells in vitro with vif-deficient VSV-G-pseudotyped HIV-1IIIB
produced in the presence of either hA3G or hA3F (6). Near-
full-length HIV-1 sequences extending from gag to the 3LTR
were amplified from cell lysates using limiting dilution PCR
(hA3G, 10 sequences, 83.7 kb total; hA3F, 9 sequences, 6 of
which contained short gaps, 68.8 kb total). The local sequence
preferences for hA3-induced mutations were determined
through comparison with the known sequence of the parental
virus. The vast majority of mutations observed in each se-
quence set were plus-strand G-to-A changes, with hA3G and
hA3F preferentially mutating 5 GG and 5 GA dinucleotide
motifs (minus-strand 5 CC and 5 TC), respectively (Tables
1 and 2), as previously described (1, 26, 47).
Influence of surrounding nucleotides on hA3-mediated mu-
tation rates. While previous studies have suggested various
preferred and disfavored wider nucleotide contexts for hA3
activity, we systematically analyzed how the likelihood of ob-
serving a G-to-A mutation depended on the wider context
around the target G nucleotide. We performed chi-square
analyses, testing the independence of mutation frequencies on
the nucleotide at each position ranging from 100 bases up-
stream to 100 bases downstream of the target G. Each indi-
vidual hypermutated provirus was first analyzed separately; P
values were subsequently combined using Fisher’s method for
combining independent tests (22) to obtain the overall proba-
bility of independence for each nucleotide in both the hA3G
and hA3F data sets (Fig. 1A and B).
For hA3G, the observed mutation rates were dependent on
the nucleotides spanning positions 2 to 3 relative to the
target G (position 0); the most significant effect was exerted by
the nucleotide at position 1, reflecting the extreme prefer-
ence for 5GG motifs (Fig. 1C). The nucleotides at positions
2 and 1 were also strong determinants of mutation fre-
quencies, while those at 3 and 2 mediated lesser, yet still
significant, effects (Fig. 1A). Similarly, GG-to-AG mutation
rates were found to be dependent on the nucleotides occupying
positions2 to3, demonstrating the importance of the wider
context of the target dinucleotide on hA3G-induced mutation
frequencies (Fig. 1B). hA3F-induced mutation rates depended
most on the nucleotide at position 1, reflecting the prefer-
ence for 5GA motifs (Fig. 1E), and were also highly influ-
enced by the nucleotide at position 2 (Fig. 1A). The data
were less conclusive regarding the influence of the nucleotides
at positions 2, 1, and 3 but were suggestive of an effect
(Fig. 1A and B).
To investigate which particular nucleotides were favored or
disfavored, the observed frequency of each nucleotide at each
of these positions was compared to its expected frequency if
mutation rates were independent of the wider nucleotide con-
text (Fig. 1C to F). These analyses indicated that the presence
of T at positions 2 and 1, G at 1 and 2, and T or A at
3 were associated with increased hA3G-induced mutation
rates; in contrast, the presence of C at positions 2 and 3
and, to a lesser extent, T at 2, was associated with lower
mutation rates (Fig. 1C and D). For hA3F, T at positions 2
and 1 (for which the chi-square test tended toward signifi-
cance), A at 1 and 2, and T at 3 were associated with
increased mutation rates, while C at positions 2, 1, 2,
and 3 was associated with reduced mutation rates (Fig. 1E
and F).
Local sequence preferences for hA3G- and hA3F-mediated
mutation of HIV-1 proviruses in vitro. To evaluate the influ-
ence of specific combinations of nucleotides on hA3-induced
deamination, we determined the mutation rates associated
with overlapping G-containing tetranucleotide contexts; anal-
ysis of overlapping tetranucleotides was used to ensure the
important2 to3 region was covered (i.e., Gnnn-to-Annn [0
to 3], nGnn-to-nAnn [1 to 2], and nnGn-to-nnAn [2 to
1] analysis), while retaining wide representation of different
types of motif (Fig. 2A and B). Raw data for these tetranucle-
otide analyses (both for individual hypermutated proviruses
TABLE 1. Summary of mutations induced in HIV-1 proviruses in
vitro by hA3G and hA3F
Parental
base
Mutated base
Total available
A C G T
hA3G
A 0 0 0 30,030
C 0 0 4 14,833
G 1,500 1 1 20,019
T 1 2 0 18,816
hA3F
A 0 0 0 24,710
C 0 0 2 12,189
G 953 0 0 16,436
T 1 2 0 15,492
TABLE 2. Summary of dinucleotide preferences of G-to-A
mutations induced in HIV-1 proviruses in vitro
by hA3G and hA3F
Gn dinucleotide
type and
mutation
No. of
mutations
No. of
available
contexts
% Contexts
mutated
95%
confidence
interval
hA3G
Gn-to-An 1,499 19,998 7.50 7.13–7.87
GA-to-AA 127 6,924 1.83 1.53–2.18
GC-to-AC 2 3,717 0.05 0.01–0.19
GG-to-AG 1,359 5,610 24.22 23.11–25.37
GT-to-AT 11 3,747 0.29 0.15–0.52
hA3F
Gn-to-An 951 16,422 5.79 5.44–6.16
GA-to-AA 718 5,701 12.59 11.74–13.48
GC-to-AC 77 3,037 2.54 2.01–3.16
GG-to-AG 136 4,597 2.96 2.49–3.49
GT-to-AT 20 3,087 0.65 0.40–1.00
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and for the pooled data sets) are presented in Fig. S2 of the
supplemental material.
For both hA3G and hA3F, the most highly mutated tet-
ranucleotide contexts contained the known target 5GG and
5GA dinucleotide motifs, respectively; hA3G targeted
5TGGG motifs almost twice as frequently as any other con-
text, and hA3F most often mutated 5TGAA motifs. For both
hA3G and hA3F, 5GNC contexts were rarely mutated, dem-
FIG. 1. The influence of surrounding nucleotides on hA3G- and hA3F-induced G-to-A mutation rates in HIV-1 proviruses in vitro. (A and B)
To analyze the influence of the surrounding nucleotides on G-to-A mutation rates, a series of chi-square analyses (with three degrees of freedom)
examining the independence of mutation rates on the nucleotide at each consecutive position from 100 nucleotides downstream to 100 nucleotides
upstream of the target plus-strand G (panel A), GG, or GA (panel B) motif were carried out (i.e., N(99X)G, N(98X)G . . . G(98X)N,
G(99X)N; or N(99X)GG . . . GG(98X)N, where the target G  position 0). Only nucleotides spanning positions 10 to 10 are shown here
for clarity; no significant deviations from independence were observed outside of this region in any data set. Each individual sequence mutated
by hA3G or hA3F was analyzed independently; P values for each nucleotide position from each sequence were then combined using Fisher’s
method for combining independent tests to assess the influence of each nucleotide position for the hA3G (blue bars) and hA3F (red bars) data
sets, respectively. Data represent the negative log10 of the P value; the dashed line indicates the value corresponding to P  0.05. (C to F) The
frequency of each nucleotide, relative to its expected frequency, at each position with respect to target G (C [hA3G] and E [hA3F]), target GG
(D, hA3G) or target GA (F, hA3F) motifs. Data points represent the mean percentages of the expected nucleotide frequency; error bars depict
the standard errors of the means; significant data are highlighted with a white background.
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onstrating the marked inhibitory effect of a C at position 2;
this effect was the strongest effect observed, overriding the
observed beneficial effect for mutation of T at position 1
(data not shown). For hA3G, mutation frequencies at the pre-
ferred GGG motifs, and also at GGA, were enhanced by the
presence of T or A at 3; the presence of a T at 2 was also
favored by hA3G. For hA3F, T at 1 was generally associated
with increased mutation frequencies. Together, these effects
make hierarchies of nucleotide substrate preferences apparent
for both hA3G and hA3F (Fig. 2A and B).
Conservation of nucleotide preference hierarchies in indi-
vidual hypermutated proviruses and subgenomic fragments.
To assess whether the tetranucleotide preference hierarchies
observed across the pooled in vitro data sets were highly in-
fluenced by subsets of individual proviruses, we compared the
mutation preferences in the pooled data sets with those in each
individual provirus. The pooled hA3G data strongly predicted
the nucleotide preference hierarchy in the majority of individ-
ual sequences, even when only GG-containing tetranucleotide
contexts were considered (Fig. 3A, categories 4, 5, and 6
[hA3G]). Similarly, although the association was less strong,
the pooled hA3F data set predicted the mutational preference
hierarchy in individual viruses mutated by hA3F, and most
sequences carried analogous mutation signatures even when
considering only GA-containing tetranucleotide contexts (Fig.
3A, categories 7, 8, and 9 [hA3F]). This suggests that for both
deaminases, considerable substrate specificity exists beyond
their preferred dinucleotide targets. Furthermore, the sub-
strate preference hierarchies existed irrespective of the level of
hypermutation in the individual sequences, although the se-
FIG. 2. Nucleotide context preferences of G-to-A mutations induced in HIV-1 proviruses by hA3G and hA3F in vitro. The tetranucleotide
mutational preferences in proviral sequences, spanning gag-3LTR, isolated from 293T cells infected with VSV-G-pseudotyped vif-deficient
HIV-1IIIB generated in the presence of hA3G (A) or hA3F (B), were analyzed relative to their known parental sequence. The proportion of each
type of available G-containing tetranucleotide context carrying G-to-A mutations (Gnnn-to-Annn, nGnn-to-nAnn, and nnGn-to-nnAn, respec-
tively) was determined; these overlapping tetranucleotides covered the region spanning positions 2 to 3 relative to the target G (position 0).
Data from the hA3G (10 sequences, 83.7kb) and hA3F (9 sequences, 68.8kb) sequence sets were pooled. Only tetranucleotide contexts with
mutation rates greater than 1% are shown; tetranucleotides highlighted in pink and blue contain the hA3G 5GG and hA3F 5GA preferred
dinucleotides, respectively; the target G nucleotide is black; the surrounding nucleotides are colored differently for clarity; error bars represent 95%
confidence intervals based on a binomial distribution.
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quences least representative of the pooled data sets tended to
be those with the lowest overall levels of mutation; however,
this may simply reflect a reduction in statistical power in these
cases.
To elucidate whether the apparent conservation of hA3G
and hA3F tetranucleotide preference hierarchies reflected
general features of the deaminase activities or was an artifact
of investigating hypermutation in the context of a particular
viral sequence, we determined whether the hierarchies were
conserved across different subgenomic regions. The hypermu-
tated proviral sequences were arbitrarily divided into four
2.1-kb fragments spanning gag-pol, pol-vif, vif-env, and env-
3LTR, and the mutation preferences were reanalyzed in each
case. For hA3G, the tetranucleotide preference hierarchy in
any given fragment was still significantly correlated with those
of any other when only nGGn contexts were considered, and
there was a significant correlation in the majority of cases when
GGnn motifs were analyzed alone (Fig. 3B). When GA-con-
taining contexts were considered alone for hA3F, the correla-
tions were less strong but still significant in most cases. These
data demonstrate that for hA3G, and to a lesser extent hA3F,
hierarchies of tetranucleotide substrate preferences exist irre-
spective of the sequence investigated and the overall level of
mutation.
hA3 footprints in naturally occurring hypermutated HIV-1
sequences. To determine the correlation between the tetranucle-
otide preferences found in vitro with those present in hypermu-
tated sequences isolated from natural infections, we analyzed the
majority of patient-derived near-full-length hypermutated provi-
ruses in the Los Alamos database (www.hiv.lanl.gov). These be-
FIG. 3. Conservation of tetranucleotide preference hierarchies in individual hypermutated proviruses and subgenomic fragments. (A) Corre-
lation between the tetranucleotide preference hierarchies observed in the pooled hA3G and hA3F data sets and in each individual provirus
comprising the pooled data sets. Spearman rank correlations between the arrays of mutation rates observed in individual sequences and the pooled
data sets were determined, considering mutation within different categories of tetranucleotide contexts; darker shades of blue indicate more highly
significant correlations; contexts with zero mutation rates were excluded, since a large number of tied ranks can compromise the Spearman’s rank
test. For each individual provirus, G-to-A, GG-to-AG, and GA-to-AA mutation rates are indicated. Weighted Poisson regression analyses were
also carried out, yielding similar results (data not shown). (B) Correlation of tetranucleotide mutational preferences observed in different
subgenomic regions of HIV-1 sequences by hA3G and hA3F in vitro. Near-full-length proviruses mutated by hA3G or hA3F were divided
arbitrarily into four 2.1-kb fragments (spanning gag-pol (HXB2 1200–3325), pol-vif (HXB2 3326–5450), vif-env (HXB2 5451–7575), and env-3LTR
(HXB2 7576–9680); four additional non-full-length (env-3LTR) sequences from the hA3G experiment and six additional non-full-length (env-
3LTR) sequences for the hA3F experiment, derived from the same infections, were added to this analysis. The correlation between the
tetranucleotide substrate preferences in each fragment with that in each other fragment, for the categories of tetranucleotide context shown, was
assessed using Spearman rank correlations, color coded as described above. Weighted Poisson regression analyses were also carried out, yielding
similar results (data not shown). Contexts with zero mutation rates were excluded.
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FIG. 4. Correlation of tetranucleotide mutational preferences observed in hypermutated HIV-1 sequences in vivo with those observed in
proviruses hypermutated by hA3G or hA3F in vitro. (A) The tetranucleotide preferences hierarchies in 43 near-full-length HIV-1 sequences
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longed to an array of subtypes. A precise characterization of
the nucleotide mutation preferences in these sequences is lim-
ited by the absence of relevant reference sequences for most of
them. Ideally, references generated from nonhypermutated se-
quences isolated from the same infected individual should be
used for analyzing a hypermutated variant, as in several studies
of hypermutated subgenomic fragments (32, 38, 40) and a
single study of a full-length O-group hypermutant (72). In the
absence of such sequences, previous studies of near-full-length
genomes have either used references generated from arbi-
trarily chosen nonhypermutated sequences from the same sub-
type or measures of G-to-A mutational burden which were
nonspecific at the nucleotide level (39, 60, 72).
To optimize our analysis of the naturally occurring near-full-
length hypermutated sequences, we developed a method to
improve reference sequence estimates; briefly, we used a com-
bination of “repairing” potential hA3-induced mutation in
each sequence alignment and subsequent phylogenetic tree
analysis to identify the most closely related nonhypermutated
sequences, from which a consensus sequence was generated for
use as a reference. Using these optimized reference sequences,
we determined the genome-wide in vivo hypermutation char-
acteristics of all near-full-length hypermutated proviruses for
which nonhypermutated genomes from the same subtype were
available.
The in vivo G-to-A mutation rates determined were typically
higher than those observed in vitro, yet the C-to-T mutation
rates were also notable. This indicates that, even after improv-
ing estimates of reference sequences as described, consider-
able genetic distance was still present between these reference
estimates and the genuine, but unknown, parental sequences;
thus, not all of the G-to-A mutations recorded were likely
accounted for by hA3 activity (Fig. 4A). Nevertheless, the
hierarchy of tetranucleotide preferences defined for hA3G-
induced mutations in vitro strongly predicted the mutation
characteristics, even when only GGnn or nGGn motifs were
included in the analysis, in 38/43 (88%) of the database se-
quences, irrespective of the overall level of hypermutation
(Fig. 4A, categories 1 to 5 [hA3G]). The tetranucleotide mu-
tation preferences of 2/43 sequences (5%) were not predicted
by the in vitro hA3G data (see Table S2, 01AE_f and 11cpx, in
the supplemental material). However, the preferences in these
two sequences did correlate with the hA3F in vitro preferences
when considering data combined for GG- and GA-containing
motifs (Fig. 4A, categories 1 to 3 [hA3F]), but not when GA-
containing tetranucleotide contexts were assessed alone (Fig.
4A, categories 7 to 9 [hA3F]). Thus, the significant correlation
was solely attributable to GG-containing contexts having low
mutation rates in both data sets. Consequently, these two pro-
viruses were more likely to have been mutated by hA3F than
hA3G.
Three subtype B proviruses, which all originated from the
same patient, carried unusual hypermutation profiles and pref-
erences (see Table S2, sequences B_f, B_g, and B_h in the
supplemental material) (81). The sequences were very similar
and highly hypermutated in gag and pol, but not elsewhere in
the genome, in contrast to most hA3G-mutated proviruses
which were hypermutated throughout the viral genome (see
Fig. S5 in the supplemental material). Moreover, the tet-
ranucleotide mutation preferences only ever correlated with
those induced by hA3G in vitro when GG- and GA-containing
tetranucleotide contexts were considered together and never
when GG-containing contexts were analyzed alone (Fig. 4A).
It is therefore less clear whether hypermutation in these se-
quences was hA3G mediated, and consequently they were ex-
cluded from later analyses.
We collated the tetranucleotide preference data for the 38
sequences carrying hA3G-like mutations; the in vivo hierar-
chies correlated strongly with those observed for hA3G activity
in vitro, even when only contexts containing the hA3G GG
target dinucleotide were considered (Fig. 4B). When we
looked at the combined hA3F-like in vivo data set, the in vitro
hA3F tetranucleotide preferences predicted the in vivo hier-
archies only when both GA- and GG-containing contexts were
considered, and the significance was lost when only contexts
containing the hA3F GA target dinucleotide were analyzed
(Fig. 4C). Thus, while the association between the in vitro and
in vivo hA3F data sets was ambiguous, the hierarchy of tet-
ranucleotide substrate preferences for hA3G activity appeared
highly conserved in vitro and in vivo.
Distinct genome-wide hA3G and hA3F hypermutation pro-
files. We next examined the distribution of hA3G- and hA3F-
induced hypermutation across the near-full-length HIV-1 pro-
viruses, accounting for the distribution of target dinucleotide
marked as hypermutated in the Los Alamos HIV sequence database were determined using reference sequences estimated as described. Each
sequence was assigned a name according to its subtype. Spearman rank correlations between the arrays of mutation rates observed in each
individual in vivo sequence and those in the pooled data sets for proviruses hypermutated in vitro by hA3G or hA3F were determined, considering
mutation within different categories of tetranucleotide contexts; darker shades of blue indicate more significant correlations. Contexts with zero
mutation rates were excluded since a large number of tied ranks can compromise the Spearman’s rank test; pairs of data for which a significant
inverse correlation was found are indicated. For each individual provirus, G-to-A, GG-to-AG, and GA-to-AA mutation rates are indicated; C-to-T
mutation rates are shown to give an indication of the noise associated with each analysis. Weighted Poisson regression analyses were also carried
out, yielding similar results (data not shown). (B) The tetranucleotide preference data (with the target guanine at either position 1, 2, or 3 of the
tetranucleotide) from the 38 in vivo proviruses carrying strong evidence of hA3G activity were pooled and correlated with the pooled tetranucle-
otide mutational preferences for proviruses hypermutated by hA3G in vitro. Each point represents a particular tetranucleotide context; GG- and
GA-containing tetranucleotide contexts are represented by black filled and unfilled circles, respectively. Spearman rank correlation P values are
indicated and take into consideration both the GG- and GA-containing contexts together, with the P values determined when only GG- or
GA-containing tetranucleotide contexts were considered (shown in parentheses); similarly, the McFadden Pseudo-R2 statistic, a measure of the
goodness of fit of the regression which accounts for the availability of each target context, is indicated. Contexts with zero mutation rates were
excluded. Error bars correspond to binomial 95% confidence intervals. (C) As for panel B, the tetranucleotide preference data (with the target
guanine either at position 1, 2, or 3 of the tetranucleotide) from the two in vivo proviruses potentially mutated by hA3F were pooled and correlated
with the pooled tetranucleotide mutational preferences for proviruses hypermutated by hA3F in vitro.
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FIG. 5. Genome-wide hypermutation profiles induced in vitro by hA3G and hA3F. Genome-wide hypermutation profiles were generated by
calculating the proportion of GG and GA dinucleotide targets mutated to AG and AA, respectively, in 400-bp sliding windows to the 3 of the base
under consideration, advancing in 1-bp steps across the genome. Consequently, the influence of a particular position on the profile commences 400
bp upstream of the position on the plot, and aberrant effects on the profiles may be observed within 400 bp of the ends of the sequences or gaps.
The exact locations of the cPPT and 3PPT in each sequence are indicated. (A) Mean profile (blue line) for proviruses hypermutated by hA3G
in vitro (representative of 10 near-full-length proviruses); brown and red lines represent plus and minus 1 standard error of the mean. For each
sequence, data for positions where less than 100 bases of actual sequence data were present in the 400-bp window (such as at the start of the
sequence or around a gap) were omitted to avoid potential skewing of the mean profiles. (B) Representative profiles of hypermutation in four
individual proviruses mutated by hA3G. The remaining profiles are shown in Fig. S4A of the supplemental material. (C) Mean profile (blue line)
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motifs (Fig. 5; see also Fig. S4 in the supplemental material).
We observed high mutation frequencies in the pol and gp41-nef
regions, with lower levels of hypermutation induced down-
stream of both PPTs, consistent with previous studies (72, 84,
86) (Fig. 5A and C). The levels of hA3G- and hA3F-induced
hypermutation typically remained low for 1 to 2 kb down-
stream of the cPPT; however, the level of mutation induced by
hA3G rapidly increased to levels similar to those observed in
the gp41-env region within 500 bp of the 3 PPT. In contrast, all
of the sequences mutated by hA3F displayed low levels of
G-to-A mutation throughout this region (Fig. 5C), except one
that carried a high mutational burden (3F117 [see Fig. S4 in
the supplemental material]).
The hA3G-induced hypermutation profiles were distinct
from those induced by hA3F (Fig. 5B and D; see also Fig. S1
in the supplemental material). While hA3G-hypermutated
proviruses carried quite conserved genome-wide hypermuta-
tion profiles, those mutated by hA3F often contained some
intensely mutated regions, while the rest of the genome con-
tained little or no hypermutation; the boundaries of the in-
tensely hypermutated regions did not necessarily coincide with
the PPTs and varied between proviruses. Some harbored in-
tensely hypermutated regions only in the 5 half of the genome;
some were only hypermutated significantly in the 3 half; oth-
ers were highly hypermutated in both halves of the genome
(Fig. 5D; see also Fig. S4 in the supplemental material). Re-
gions of intense hypermutation frequently contained runs of
guanine bases followed by an adenine (GnA motifs; n  1) in
which several of the Gs preceding the conventional GA target
dinucleotide also were mutated; indeed, for over 70% of the
hA3F-mediated mutations classified as GG-to-AG mutations
(Table 2), the following G was also mutated (i.e., equivalent to
the GGA-to-AAA mutation [data not shown]), which is con-
sistent with hA3F creating new GA target dinucleotides for
itself (i.e., GGA-to-GAA-to-AAA).
We did similar profile analysis of individual hA3G-hypermu-
tated genomes derived from natural infections. In most cases,
regardless of subtype, mutational minima existed at positions
corresponding to the PPTs, with levels of hypermutation in-
creasing toward pol and in the gp41-nef region (Fig. 6; see also
Fig. S5 in the supplemental material). Analogous to the pat-
terns of mutation induced in vitro by hA3G, the level of hy-
permutation frequently remained low 1 to 2 kb downstream of
the cPPT while increasing to higher levels within 500 bp of the
3 PPT. Of the two proviruses potentially hypermutated by
hA3F in vivo (Fig. 4A and C), one (11cpx) displayed a muta-
tional profile similar to that induced by hA3F in vitro, with
short regions of intense hypermutation, while the other
(01AE_f) displayed high levels of hypermutation throughout
the genome (Fig. 6).
Two HERV-K(HML2) variants carry footprints of hA3G
activity. The A3 proteins have been under strong positive se-
lection throughout primate evolution, suggesting they have
been important in defense against pathogens or mobile genetic
elements for millions of years (63, 91). Many proviruses from
the Pmv and Mpmv subgroups of endogenous nonecotropic
MLVs carry signatures of mA3 activity, which may have con-
tributed to their inactivation (34), and the ability of the hA3
proteins to restrict other types of endogenous retroelements
has been demonstrated (8, 14, 17, 20, 21, 58, 65, 70).
The HERV sequences in the human genome provide a large
archive of ancestral retroviral infections that were conceivably
targets for the hA3 proteins. To analyze whether any HERV
sequences carried footprints of hA3 activity in the same man-
ner as the in vivo hypermutated HIV-1 proviruses, we deter-
mined the mutational preferences in members of the HERV-
K(HML2) family, the most recently active lineage in humans.
Each element was initially aligned to the consensus sequence
of the major lineage to which it belonged (shown in Fig. 3 in
Belshaw et al. [3]), and GR-to-AR and GY-to-AY mutation
rates were determined (R  a purine, A or G; Y  a pyrim-
idine, C or T). The HIV-1 proviruses hypermutated by hA3G
or hA3F in vitro displayed a marked bias toward plus-strand
GR-to-AR (R  purine, A or G) mutation over GY-to-AY
(Y  pyrimidine, C or T) mutations (chi-square test for inde-
pendence of GR-to-AR and GY-to-AY mutation rates, P 
10200 for hA3G and P  1070 for hA3F). Chi-square tests
were therefore carried out for each HERV-K(HML2) element
to screen for potential hA3-mediated hypermutation.
After Bonferroni correction for multiple testing, 3 out of 44
elements displayed significantly different mutation rates at GR
and GY dinucleotides. These included two elements, 11c21
(P  1024) and 158c3 (P  109), which had previously been
shown to carry 11 of the 16 stop codons on internal branches of
a HERV-K(HML2) phylogenetic tree; moreover, their branch
lengths were longer than those of the surrounding elements
(3). These characteristics were initially presumed to reflect the
use of complementation in trans as a second mode of replica-
tion in the HERV-K(HML2) family (3). However, we noticed
that, unlike in other HERV-K(HML2) elements with long
branch lengths and multiple stop codons, a high proportion of
the stop codons occurred as Trp-to-stop mutations (75% in
each case [data not shown]). Thus, these elements displayed
several features of hA3-induced hypermutation: long branch
lengths on a phylogenetic tree, abundant common Trp-to-stop
mutations, and an excessive burden of GR-to-AR mutations.
The third element identified was 103c19 (P  0.00025). An
apparent bias for mutation of GR over GY motifs was also
observed in a few other elements, but these correlations were
not significant after Bonferroni correction (data not shown).
We generated improved reference sequence estimates for
each of these three elements and characterized the tetranucle-
otide preference hierarchies in each. The preference hierar-
chies for elements 11c21 and 158c3 correlated strongly with the
for proviruses hypermutated by hA3F in vitro (representative of nine near-full-length proviruses, six of which contained short gaps); brown and
red lines represent plus and minus 1 standard error of the mean. For each sequence, data for positions where less than 100 bases of actual sequence
data were present in the 400-bp window (such as at the start of the sequence or around a gap) were omitted to avoid potential skewing of the mean
profiles. (D) Representative profiles of hypermutation in four individual proviruses mutated by hA3F. The positions of gaps in sequences are
marked with gray boxes. The remaining profiles are shown in Fig. S4B of the supplemental material.
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FIG. 6. Representative profiles of hypermutation in proviruses derived from natural infections. Profiles of hypermutation across each near-
full-length in vivo genome investigated were generated by calculating the proportion of target GG and GA dinucleotides mutated to AG and AA,
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hA3G tetranucleotide hierarchies determined by analyzing hy-
permutation in HIV-1 in vitro; the correlations were highly
significant even when only GG-containing tetranucleotides
were considered (target G at positions 1 or 2 of the tetranucle-
otide) and when the data were pooled (Fig. 7A, categories 4
and 5, and B). In contrast, the mutational preferences of
103c19 did not correlate significantly with the preferences ob-
served in the hypermutated HIV-1 sequences (Fig. 7A). A
short region of the genome demonstrating hypermutation in
elements 11c21 and 158c3 is shown in Fig. 7C.
Thus, our results strongly suggest that the hypermutation
found in elements 11c21 and 158c3 was induced by hA3G,
while it remains unknown whether the apparent bias for mu-
tation at GR motifs in element 103c19, and in the other se-
quences tending toward such a bias, was due to the activity of
one or more hA3 proteins, or not.
Hypermutation profiles in HERV-K (HML2) reveal putative
cPPT and CTS regions. We analyzed the mutational profiles
across the two hypermutated HERV-K(HML2) elements (Fig.
8A). As in hypermutated HIV-1 sequences, mutation levels
decreased at the 3 PPT; however, while the data were ambig-
uous with regard to the existence of hypermutational gradients,
an additional reduction in hypermutation levels was found in
both proviruses near the 3 end of the pol gene at a position
corresponding to a putative PPT-like sequence (5-AAAAAG
AAGGGGGAG-3). A central termination site (CTS)-like se-
quence, characterized by a dA3-dT6 motif (12), occurred 57 bp
downstream of the putative cPPT. These sequence motifs are
analogous to those present in the HIV-1 genome, which permit
initiation of plus-strand cDNA synthesis from a second site and
formation of the central DNA flap (12, 89).
We hypothesized that if the putative cPPT and CTS se-
quences were functionally significant for HERV-K(HML2)
replication in general, they should be conserved in other
HERV-K(HML2) sequences. While the CTS sequence was
found in 43 of the 44 near-full-length HERV-K(HML2) ge-
nomes (element 84c1 carried a deletion in this region), the
specific PPT-like motif was not so conserved. When we super-
imposed the putative cPPT region on a phylogenetic tree based
on these sequences, it was apparent that the presence or ab-
sence of the cPPT motif correlated with the separation of the
two major HERV-K(HML2) lineages, close to the root of the
tree; the putative cPPT motif was only conserved in lineage 1.
However, the sequence present at this location in lineage 2 was
also composed entirely of purines, so a similar functional role
cannot be excluded (Fig. 8B) (3). Removing the putative cPPT
and CTS motifs from the alignment had no effect on the overall
topology of the tree (data not shown). Furthermore, the pre-
vious nonphylogenetic designation of HERV-K(HML2) into
type 1 and type 2 subgroups, based on the presence or absence
of a 292-bp deletion at the pol-env boundary, did not correlate
with these lineages (Fig. 8B) (3, 49).
DISCUSSION
Here, we demonstrate that hA3G and, to a lesser extent,
hA3F leave well-defined footprints of mutational activity on
retroviral sequences, beyond their known dinucleotide signa-
tures (1, 47, 90). While some wider nucleotide motifs have
been previously reported as preferred or disfavored substrates
for hA3G and hA3F (1, 6, 13, 47, 73, 86), we show that the
nucleotides spanning the region 2 nucleotides upstream to 3
nucleotides downstream of a target plus-strand G significantly
influence the likelihood of a G-to-A mutation occurring; in
addition, we present detailed tetranucleotide preference hier-
archies for both deaminases. Furthermore, we show that the
hA3G preference hierarchies are conserved not only in hyper-
mutated HIV-1 proviruses in vitro and in vivo but also in two
hypermutated members of the HERV-K(HML2) family of hu-
man endogenous retroviruses.
The highly significant correlation between the hA3G tet-
ranucleotide preferences in vitro and in vivo suggests this
deaminase was responsible for the hypermutation observed in
vivo. The substrate preference hierarchies were apparent even
when we analyzed only those tetranucleotide contexts that
contained the preferred hA3G dinucleotide 5GG target (i.e.,
GGnn and nGGn), further demonstrating that the target con-
text wider than the dinucleotide strongly influences the likeli-
hood of hA3G inducing a mutation. These hierarchies were
typically maintained irrespective of the overall level of hyper-
mutation both in vitro and in vivo.
In contrast, although the hA3F-induced mutation prefer-
ences appeared consistent in most hypermutated proviruses in
vitro, they did not correlate significantly with those from the
sequences carrying predominantly hA3F-type GA-to-AA mu-
tations in vivo when we considered GA-containing tetranucle-
otide motifs alone (i.e., GAnn and nGAn). This may reflect
either the smaller hA3F sample size, that the nucleotide pref-
erences for hA3F activity are less conserved beyond the dinu-
cleotide level, or that one or both of these two sequences were
mutated by an hA3F-independent mechanism (e.g., other hA3
family members, such as hA3B [6]).
Irrespective of subtype, over 85% of the in vivo hypermu-
tated HIV-1 proviruses carried clear signatures of hA3G ac-
tivity and no more than 5% carried footprints of hA3F activity,
although we cannot exclude the existence of low-level hA3F
mutation in sequences carrying large amounts of hA3G-like
mutations. The overrepresentation of proviruses carrying
respectively, in 400-bp sliding windows to the 3 of the base under consideration, advancing in 1-bp steps across the genome. Consequently, the
influence of a particular position on the profile commences 400 bp upstream of the position on the plot, and aberrant effects on the profiles may
be observed within 400 bp of the end of the sequence. Sequence names according to subtype, as given in Table S2 of the supplemental material,
are shown, together with the GenBank accession number of the sequence. The marked locations of the cPPT and 3PPT indicated for each
sequence are exact; these do not necessarily align with the approximate genome maps shown, as the lengths of the hypermutated sequences
analyzed were variable. GG-to-AG and GA-to-AA mutation rates are indicated, together with the equivalent minus-strand mutations (plus-strand
CC-to-CT and TC-to-TT) to give an indication of the noise associated with each analysis. The panels highlighted in blue indicate the proviruses
carrying predominantly hA3F-type 5GA-to-AA mutations; the remainder carried predominantly hA3G-type 5GG-to-AG mutations. The
remaining profiles are shown in Fig. S5 of the supplemental material.
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FIG. 7. Correlation of tetranucleotide mutational preferences in naturally occurring hypermutated HERV-K(HML2) sequences with those
observed in proviruses hypermutated in vitro by hA3G or hA3F. (A) HERV-K(HML2) proviruses were screened for hypermutation as described
elsewhere. The tetranucleotide mutational preference hierarchies in the HERV-K(HML2) elements carrying evidence of potential hA3 activity
(11c21, 103c19, and 158c3) were determined using improved reference sequences estimated as described elsewhere. Spearman rank correlations
between the arrays of mutation rates observed in each element and those in the pooled data sets for proviruses hypermutated in vitro by hA3G
or hA3F were determined, considering mutation within different categories of tetranucleotide contexts. Darker shades of blue indicate more
significant correlations; contexts with zero mutation rates were excluded, since a large number of tied ranks can compromise the Spearman’s rank
test. Pairs of data for which a significant inverse correlation was found are indicated. For each HERV-K(HML2) element, G-to-A, GG-to-AG, and
GA-to-AA mutation rates are indicated; C-to-T mutation rates are shown to give an indication of the noise associated with each analysis. Weighted
Poisson regression analyses were also carried out, yielding similar results (data not shown). (B) The tetranucleotide preference data (with the target
G either at position 1, 2, or 3 of the tetranucleotide) from the two HERV-K(HML2) elements that showed strong evidence of hA3G activity (11c21
and 158c3) were pooled and correlated with the pooled tetranucleotide mutational preferences for proviruses hypermutated by hA3G in vitro.
Each point represents a particular tetranucleotide context; GG- and GA-containing tetranucleotide contexts are represented by black-filled and
unfilled circles, respectively. Spearman rank correlation P values are indicated and were generated considering both the GG- and GA-containing
contexts together, with the P values determined when only GG- or GA-containing tetranucleotide contexts were considered shown in parentheses;
similarly, the McFadden Pseudo-R2 statistic, a measure of the goodness of fit of the regression, is indicated. Contexts with zero mutation rates were
excluded. Error bars correspond to binomial 95% confidence intervals. (C) Section of HERV-K(HML2) gag sequence from hypermutated
elements 11c21 and 158c3.
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hA3G-like mutations appears to contradict previous sugges-
tions that hA3F is the major contributor to hypermutation in
natural HIV infections (47). This proposal was based in part on
the observation that hA3F is partially resistant to HIV-1 Vif in
vitro, as well as on the predominance of GA-to-AA mutations
in a short fragment of the HIV-1 protease gene from one set of
patients (32, 47). Assuming no significant biases in sampling or
amplification of hA3G- and hA3F-hypermutated sequences
within the database samples, which are derived from several
independent studies, our data are consistent with hA3G being
the major contributor to hypermutation in vivo. However,
while hypermutation provides a useful diagnostic marker of
hA3G and hA3F activity, we emphasize that it cannot be used
to conclude that one or the other deaminase is more significant
in terms of the overall hA3-mediated antiviral effect. More
specifically, there is evidence that hA3 proteins may exert
antiviral phenotypes in the absence of DNA editing in vitro (5,
24, 25, 28, 29, 31, 46, 50, 54, 57, 59, 64, 85).
Our data are consistent with earlier reports demonstrating
the influence of the PPTs on the genome-wide hypermutation
profiles (72, 84, 86). In the majority of sequences hypermu-
tated in vitro and in vivo by hA3G, and in vitro by hA3F,
reductions in mutation frequencies were observed in the
genomic regions immediately downstream from the PPTs,
which are exposed as single-stranded DNA for the shortest
times during reverse transcription. However, since high levels
FIG. 8. Conservation of putative cPPT and CTS motifs in a group of HERV-K(HML2) elements. (A) Hypermutation profiles across the
HERV-K(HML2) elements 11c21 (blue line) and 158c3 (red line) were generated by calculating the proportion of target GG and GA dinucleotides
mutated to AG and AA, respectively, in 400-bp sliding windows to the 3 of the base under consideration, advancing in 1-bp steps across the
genome. Consequently, the influence of a particular position on the profile commences 400 bp upstream of the position on the plot, and aberrant
effects on the profiles may be observed within 400 bp of the ends of the sequences. The position of a common reduction in hypermutational burden
in the two sequences is indicated. GG-to-AG and GA-to-AA mutation rates are indicated, together with the equivalent minus-strand mutations
(plus-strand CC-to-CT and TC-to-TT) to give an indication of the noise associated with each analysis. (B) Maximum likelihood tree generated from
44 near-full-length HERV-K elements; the hA3-type mutations within the hypermutated elements 11c21 (blue) and 158c3 (red), denoted HR, were
repaired prior to construction of the tree. The human-specific subgroup of HERV-K(HML2) elements is indicated in green. An alignment of the
putative cPPT and CTS regions for each HERV-K(HML2) element in the tree is shown, with the two major lineages designated lineage 1 and
lineage 2. The two regions are separated by 57 bp. No sequence for this region is present in element 84c1. Type 1 HERV-K(HML2) sequences,
characterized by a 292-bp deletion at the pol-env boundary, are indicated with a black circle; all others are type 2 sequences. The HIV-1 cPPT and
CTS sequences are shown for comparison.
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of mutation were observed relatively close to the 3 PPT in
sequences hypermutated by hA3G, factors other than time
exposed as single-stranded DNA may modify the hA3G-sub-
strate interactions.
In contrast to the quite conserved genome-wide hypermuta-
tion profiles induced by hA3G, hA3F activity resulted in spo-
radic regions of intense hypermutation and other regions with
little or no hypermutation, despite the availability of hA3F
target motifs throughout the HIV-1 genome. The intensely
hypermutated regions often included mutation of several con-
secutive guanines in plus-strand 5 GnA (n  1) motifs, which
is consistent with hA3F creating novel target dinucleotides for
itself. However, it is unknown whether these multiple muta-
tions are caused by a single hA3F unit, processively mutating,
creating, and itself mutating the newly created targets, or by
multiple deaminases subsequently encountering newly created
minus-strand 5TC substrates. If these multiple mutations were
catalyzed by a single hA3F unit, it would imply hA3F processed
in a minus-strand 5-to-3 direction, in contrast to hA3G, which
has been shown to act processively on target oligonucleotides
in a minus-strand 3-to-5 direction in vitro (13). For both
hA3G- and hA3F-mediated mutation, the time that DNA is
exposed as a single strand, together with the distribution of
preferred target motifs, and other as-yet-undefined factors,
likely combine to determine the observed hypermutation pro-
files.
The hA3 proteins have been shown to be under strong pos-
itive selection throughout primate evolution (63, 91) and are
expressed at high levels in testis, specifically in the ductus
seminiferous (where spermatozoa are generated), and in the
ovaries; the retrotransposition events that lead to endogeniza-
tion must occur in these tissues (33, 77). Consequently, they
have been suggested to play a role in protection against po-
tentially detrimental transmission of functional retroelements
(27, 63). Here, we present evidence that hA3G activity has
influenced the natural history of HERVs, as 2 out of 44
HERV-K(HML2) elements were found to carry mutational
signatures that correlated strongly with the footprints of hA3G
activity observed in hypermutated HIV-1 genomes. These el-
ements, 11c21 and 158c3, are unique to humans and occur near
the base of the human-specific HERV-K(HML2) subgroup,
which suggests that they are several million years old (2). Other
HERV-K(HML2) family members also harbored higher num-
bers of GR-to-AR than GY-to-AY mutations and were there-
fore also potentially influenced by lower-level hA3 activity. For
hypermutation to have occurred in these HERV-K(HML2)
elements, we presume that hA3G became incorporated into
HERV-K(HML2) virions that subsequently infected germ line
cells, where it induced deamination of nascent viral DNA,
prior to integration. The presence of these hypermutated ele-
ments in the human genome reveals that hA3G activity did not
prevent transmission to offspring of HERV genetic material
but may have reduced potential detrimental effects associated
with transmission of functional, nonhypermutated retroviruses.
However, since only 2 out of 44 HERV-K(HML2) elements
carried footprints of hA3G activity, the extent of its protective
effect against these retroviruses may be limited. Proviruses of
the Pmv and Mpmv subgroups of nonecotropic MLVs are
proposed to have been inactivated, at least in part, by mA3-
induced deamination (34); consistent with this proposition is
the lack of purifying selection within these subgroups of mu-
rine ERVs. In contrast, the HERV-K(HML2) family has been
under continuous purifying selection (like the Xmv subgroup
of nonecotropic MLVs) and therefore largely has not been
inactivated by hA3 proteins (3, 34). Nevertheless, the presence
of hA3G-type hypermutation in two HERV-K(HML2) ele-
ments illustrates that these retroviruses have some susceptibil-
ity to this restriction factor in vivo. It may be of note that the
proportion of the HERV-K(HML2) family carrying hA3G-
type hypermutation is similar in magnitude to the proportion
of HIV-1 proviruses bearing hypermutation in natural HIV-1
infections (38). HERV-K(HML2) may therefore have em-
ployed a means of hA3 evasion, functionally analogous to that
mediated by Vif in HIV-1 infection, possibly explaining the
lack of hA3G footprints in the majority of family members.
Our results may appear to contradict those of Lee and Bie-
niasz who, using an in vitro infectivity assay, demonstrated that
a reconstituted HERV-K(HML2) virus was resistant to hA3G
but sensitive to inhibition by hA3F (45). However, our data
demonstrate that in vivo hypermutated HIV-1 sequences fre-
quently carry footprints of hA3G activity, even though in vitro
infectivity assays have suggested that, owing to Vif, wild-type
HIV-1 is resistant to hA3G in the virus’ natural target cells (23,
66, 68, 80). Therefore, the ability of the cytidine deaminases to
reduce infectivity in an in vitro assay does not necessarily
correlate with the presence of hypermutation in vivo. In spite
of this, we would like to highlight that the apparent absence of
hA3F-type mutations does not exclude that hA3F may also
have influenced the natural history of these viruses.
As with hypermutated HIV-1 sequences, the mutational pro-
files of the HERV-K(HML2) elements showed reductions in
mutation levels at the 3 PPT. Furthermore, they allowed iden-
tification of a putative cPPT for priming plus-strand DNA
synthesis in the HERV-K(HML2) family, as a decrease in
hypermutation levels was observed toward the 3 end of the pol
gene, where a PPT-like motif was located. In hypermutated
HIV-1 sequences, such reductions were seen downstream of
the cPPT, which is also located toward the 3 end of pol. This
effect was lost in an HIV-1 variant carrying a mutated, non-
functional cPPT motif (84). Consequently, the observed reduc-
tion in hypermutation in the HERV-K(HML2) elements are
consistent with this putative cPPT being functional. Moreover,
a CTS-like sequence (dA3-dT6) (12, 43) was present 57 bp
downstream from the putative cPPT; similar motifs, located 88
and 98 bp downstream from the HIV-1 cPPT, mediate termi-
nation of plus-strand synthesis and formation of the central
DNA flap (12, 18, 89). The importance of the combination of
the cPPT and CTS-like sequences is suggested by their con-
servation over millions of years across one of the two HERV-
K(HML2) lineages. Several of the more complex genera of
retroviruses have been reported to possess cPPTs, including
the lentiviruses (e.g., HIV-1 [10, 11], visna virus [7], feline
immunodefiency virus [82], and equine infectious anemia virus
[71]), spumaviruses (82), and piscine epsilon-retroviruses (e.g.,
walleye dermal sarcoma virus [30], walleye epidermal hyper-
plasia virus [42], and Atlantic salmon swim sarcoma viruses,
phylogenetically placed between gamma- and epsilon-retrovi-
ral genera [61]). The functional relevance of these sequence
signatures could be examined through site-directed mutagen-
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esis of the motifs in the recently reconstituted HERV-
K(HML2)-like viruses (16, 45).
It would be interesting to investigate whether members of
other HERV families carry evidence of hA3 activity. However,
many HERV families exhibit extreme “star-like” phylogenies,
characterized by short internal and long terminal branch
lengths, most likely due to accumulation of a large number of
neutral mutations, induced postintegration (36). These would
greatly increase the noise in similar analyses and would con-
sequently make detection of hA3 activity more difficult than
for HERV-K(HML2).
In summary, our study defines detailed and conserved nu-
cleotide preferences for hA3G-mediated hypermutation and
suggests different genome-wide mutational profiles for hA3G
and hA3F. Such data will prove useful in assessing the contri-
butions of the various hA3 proteins, particularly hA3G, to the
generation of genetic diversity observed in natural retroviral
infections. Moreover, this analysis provides the most direct
evidence to date that hA3G has been in conflict with retrovi-
ruses over millions of years of human evolution.
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